Results 251 to 260 of about 141,634 (350)
Oral microbial alterations by smoking and metabolic factors in esophageal squamous cell carcinoma. [PDF]
Jung K +6 more
europepmc +1 more source
ABSTRACT Congenital esophageal muscularis propria defects are extremely rare, often complicating endoscopic submucosal dissection (ESD) for esophageal neoplasms. We report a 60‐year‐old man with early esophageal squamous cell carcinoma who underwent ESD.
Ying Liu +4 more
wiley +1 more source
Correction: MEIS1 knockdown upregulates WNT signaling pathway genes in esophageal squamous cell carcinoma. [PDF]
Hosseini N, Forghanifard MM.
europepmc +1 more source
The role of molecular biology in diagnosis and follow-up in Barrett’s Esophagus [PDF]
Geboes, Karen, Hoorens, Anne
core +2 more sources
ABSTRACT Subepithelial lesions (SELs) of the head and neck have a low diagnostic yield with mucosal biopsy and carry a bleeding risk. Among endoscopic ultrasound–tissue acquisition (EUS‐TA) techniques, fine‐needle biopsy (FNB) provides higher specimen adequacy and diagnostic accuracy than fine‐needle aspiration (FNA).
Kakeru Otomo +9 more
wiley +1 more source
Fistulizing, Lower Esophageal Squamous Cell Carcinoma After Heller Myotomy With Fundoplication in a Patient With Achalasia. [PDF]
Zhao D, Brar K, Mittal A, Vaziri H.
europepmc +1 more source
Abstract Background and Aims Although Brunner's glands (BGs), located in the submucosa of the duodenum, may be involved by tumor cells of superficial non‐ampullary duodenal epithelial tumors (SNADETs), the detailed incidence and histopathological features have not yet been analyzed. This study aimed to clarify the histopathological relationship between
Kazuki Takayama +15 more
wiley +1 more source
New Gene Signature-Based Prognostic Model for Patients With VEGF-Overexpressing Esophageal Squamous Cell Carcinoma. [PDF]
Li Y +6 more
europepmc +1 more source
What's New? Patients with esophageal or gastroesophageal junction (GEJ) cancer with residual disease after treatment with neoadjuvant chemoradiotherapy (nCRT) and resection frequently experience poor survival. Improvements in outcome, however, may be possible using adjuvant treatment with nivolumab.
Rob H. A. Verhoeven +9 more
wiley +1 more source

